Complexity of new logistics policy may stunt China vaccine industry, Sinovac
Sinovac’s vaccine sales recovered in Q3 after it restarted activities halted while it brought operations into line with new Chinese distribution regulations.
Sinovac’s vaccine sales recovered in Q3 after it restarted activities halted while it brought operations into line with new Chinese distribution regulations.
AstrzaZeneca’s MedImmune has set up a spin-out company with Abpro that will develop a bi-specific antibody therapeutic.
WuXi Biologics will make a recombinant soluble LAG-3 protein on behalf of Prima Biomed from its 28,000L single-use facility in China set to open next year.
Lion Biotechnologies has expanded its ‘favorable’ existing relationship with WuXi AppTec to manufacture its autologous cell therapy products.